Category: Healthcare

New treatment unmatched by any competitor

Ultralase, the vision correction specialist, has today announced the launch of a new treatment, Ultraelite. Ultraelite uses technology which has the potential to deliver the best quality of vision of any laser eye surgery currently available to the UK and Irish market and will be offered at Ultralase clinics nationwide.

Using technology more advanced than is available on any other laser platform, Ultraelite represents the pinnacle of laser treatment options and has promise to deliver the most precise and accurate laser vision correction available in the UK and Ireland.

 

The new surgery benefits from building on existing treatments using wavefront technology. Whilst existing earlier wavefront treatments produce excellent quality of vision and patient satisfaction, detailed scientific analysis identified one more way to make the treatment better still, the result being the development of Ultraelite.

Constantly at the forefront of vision correction, Ultraelite has undergone extensive development work and trials with outstanding results. Singapore was chosen as the venue for this development and testing, boasting a wealth of highly experienced laser surgeons. The results of the testing show that 99.3% of those treated reported improvement in the quality of their vision.

Mark Korolkiewicz, clinical services director commented: “Ultraelite is the very latest and most advanced development in laser eye surgery and the result of our continued investment in technology and procedural advancement. Unique to Ultralase, this revolutionary treatment is performed by surgeons who have been certified by the Royal College of Ophthalmologists, the very highest industry accreditation, offering our patients the pinnacle in laser vision correction treatment quality.”

With prices starting from £1,995 per eye, Ultraelite will be available Ultralase’s 32 clinics across the UK and Ireland. For more information about Ultralase visit www.ultralase.com or call 0800 9888 237.